|
Reference |
Supplier |
Description |
Unit |
Price excl. taxes |
|
|
|
USP-1477591 |
USP |
Parallel Dimer-Octreotide (Bis{D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-L-cysteinamide} cyclic (2-->2'),(7-->7')-bis(disulfide)) - Biologic 10 mg |
|
2,084.00 CHF
2,188.20 €
|
|
|
|
USP-1477592 |
USP |
Anti-Parallel Dimer-Octreotide (Bis{D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-L-cysteinamide} cyclic (2-->7'),(2'-->7)-bis(disulfide)) - Biologic 10 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1477604 |
USP |
Octreotide Acetate - Biologic - (COLD SHIPMENT REQUIRED) 4,37 mg |
|
1,660.00 CHF
1,743.00 €
|
|
|
|
USP-1477615 |
USP |
Octreotide Non-Cyclic System Suitability Marker - Biologic - (COLD SHIPMENT REQUIRED) 20 mg |
|
1,740.00 CHF
1,827.00 €
|
|
|
|
USP-1477690 |
USP |
N-Acetyl-Lys-Octreotide Trifluoroacetate (See USP Certificate for full Chemical Name) - Biologic 25 mg |
|
1,389.33 CHF
1,458.80 €
|
|
|
|
USP-1477691 |
USP |
N-Acetyl-Phe-Octreotide Trifluoroacetate (See USP Product Information Sheet for Full Chemical Name) - Biologic 25 mg |
|
2,604.00 CHF
2,734.20 €
|
|
|
|
USP-1477808 |
USP |
Octyldodecanol 3 x 100 mg |
|
512.00 CHF
537.60 €
|
|
|
|
USP-1477900 |
USP |
Octinoxate (2-Ethylhexyl 4-methoxycinnamate) 500 mg |
|
492.00 CHF
516.60 €
|
|
|
|
USP-1477943 |
USP |
Octisalate (Octyl salicylate, Benzoic acid, 2-hydroxy-, 2-ethylhexyl ester) 400 mg |
|
492.00 CHF
516.60 €
|
|
|
|
USP-1478083 |
USP |
R-Ofloxacin (25 mg) ((R)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid) 25 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478108 |
USP |
Ofloxacin 200 mg |
|
492.00 CHF
516.60 €
|
|
|
|
USP-1478119 |
USP |
Ofloxacin Related Compound A - 9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid 25 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478130 |
USP |
Oleic Acid 1 g |
|
530.67 CHF
557.20 €
|
|
|
|
USP-1478141 |
USP |
Oleanolic Acid (15 mg) ((3beta)-3-hydroxyolean-12-en-28-oic acid) 15 mg |
|
429.33 CHF
450.80 €
|
|
|
|
USP-1478152 |
USP |
Oleoyl Polyoxylglycerides 100 mg |
|
557.33 CHF
585.20 €
|
|
|
|
USP-1478163 |
USP |
Oleuropein - (Methyl (2S,3E,4S)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-2H-pyran-5-carboxylate) 25 mg |
|
434.67 CHF
456.40 €
|
|
|
|
USP-1478174 |
USP |
Oleyl Oleate 95 125 mg |
|
534.67 CHF
561.40 €
|
|
|
|
USP-1478185 |
USP |
Oleyl Alcohol 5 x 50 mg |
|
530.67 CHF
557.20 €
|
|
|
|
USP-1478196 |
USP |
Oleyl Stearate 50 mg |
|
512.00 CHF
537.60 €
|
|
|
|
USP-1478200 |
USP |
Oley Oleate 0,5 mL |
|
512.00 CHF
537.60 €
|
|
|
|
USP-1478210 |
USP |
Oligosaccharide System Suitability Mixture A - Biologic 0,02 mg |
|
1,676.00 CHF
1,759.80 €
|
|
|
|
USP-1478221 |
USP |
Oligosaccharide System Suitability Mixture B - Biologic 0,02 mg |
|
1,509.33 CHF
1,584.80 €
|
|
|
|
USP-1478232 |
USP |
Oligosaccharide System Suitability Mixture C - Biologic 0,02 mg |
|
1,052.00 CHF
1,104.60 €
|
|
|
|
USP-1478243 |
USP |
Oligosaccharide System Suitability Mixture D - Biologic 0,02 mg |
|
1,198.67 CHF
1,258.60 €
|
|
|
|
USP-1478254 |
USP |
Olive Oil 1 g |
|
465.33 CHF
488.60 €
|
|
|
|
USP-1478265 |
USP |
Olive Leaf Dry Extract - Mixture containing about 20% w/w of Oleuropein 500 mg |
|
226.67 CHF
238.00 €
|
|
|
|
USP-1478301 |
USP |
Olanzapine 200 mg |
|
474.67 CHF
498.40 €
|
|
|
|
USP-1478312 |
USP |
Olanzapine Related Compound A - 5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile 15 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478323 |
USP |
Olanzapine Related Compound B - 2-methyl-10H-thieno-[2,3-b][1,5]benzodiazepin-4[5H]-one 15 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478334 |
USP |
Olanzapine Related Compound C - 2-methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine 4'-N-oxide (COLD SHIPMENT REQUIRED) 5 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478367 |
USP |
Olmesartan Medoxomil 100 mg |
|
957.33 CHF
1,005.20 €
|
|
|
|
USP-1478378 |
USP |
Olmesartan Medoxomil Related Compound A - 1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one 20 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478403 |
USP |
Olopatadine Hydrochloride 150 mg |
|
672.00 CHF
705.60 €
|
|
|
|
USP-1478425 |
USP |
Olopatadine Related Compound B - (Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide 35 mg |
|
1,573.33 CHF
1,652.00 €
|
|
|
|
USP-1478436 |
USP |
Olopatadine Related Compound C - (11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid 35 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478442 |
USP |
Omega-3 Free Fatty Acids ((Mixture of omega-3 fatty acids) 750 mg |
|
948.00 CHF
995.40 €
|
|
|
|
USP-1478479 |
USP |
R-Omeprazole (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt) 15 mg |
|
1,429.33 CHF
1,500.80 €
|
|
|
|
USP-1478480 |
USP |
Omeprazole Related Compound B (5-Methoxy-1H-benzimidazol-2-thiol) 15 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478491 |
USP |
Omeprazole Related Compound F and G Mixture 25 mg |
|
1,604.00 CHF
1,684.20 €
|
|
|
|
USP-1478505 |
USP |
Omeprazole 200 mg |
|
492.00 CHF
516.60 €
|
|
|
|
USP-1478516 |
USP |
Omeprazole Related Compound A - Omeprazole Sulfone or 5-methoxy-2-[[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulphonyl]-1H-benzimidazole 15 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478527 |
USP |
Omeprazole Related Compound E 15 mg |
|
1,454.67 CHF
1,527.40 €
|
|
|
|
USP-1478549 |
USP |
Omeprazole Magnesium 10 mg |
|
493.33 CHF
518.00 €
|
|
|
|
USP-1478561 |
USP |
Omeprazole Related Compound I (4-Methoxy-2-[[(5-methoxy-1H-benzimidazol-2-yl)sulfonyl]methyl]-3,5-dimethylpyridine 1-oxide) 15 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478571 |
USP |
Ondansetron (9-Methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one) 300 mg |
|
696.00 CHF
730.80 €
|
|
|
|
USP-1478582 |
USP |
Ondansetron Hydrochloride (9-Methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride dihydrate) 300 mg |
|
653.33 CHF
686.00 €
|
|
|
|
USP-1478593 |
USP |
Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride) 50 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478618 |
USP |
Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one) 30 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478629 |
USP |
Ondansetron Related Compound D - 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one 30 mg |
|
1,568.00 CHF
1,646.40 €
|
|
|
|
USP-1478630 |
USP |
Ondansetron Resolution Mixture 50 mg |
|
1,653.33 CHF
1,736.00 €
|
|
